Belgium Unveils Incentives For Biosimilar Adalimumab And Etanercept

 
• By Dave Wallace

Belgium has introduced financial incentives to encourage doctors to prescribe anti-TNF biosimilars adalimumab and etanercept outside of hospitals.

BelgiumCoin
Belgium Has Introduced A Financial Incentive To Encourage Biosimilar Uptake • Source: Shutterstock

More from Biosimilars

More from Products